Home / drug / D-0012-2026 Class II Reported 2025-10-15
Major ChlorproMAZINE Hydrochloride Tablets, USP, 100 mg, 100 Tablets (10x10) blister package, Rx Only, Packaged and Distributed by Major Pharmaceuticals, Indianapolis, IN 46268, USA, NDC 0904-7132-61, UPC (01)00309047132614 Recalled by The Harvard Drug Group LLC dba Major Pharmaceuticals and Rugby Laboratories
Reason for Recall CGMP Deviations: Presence of N-Nitroso Desmethyl Chlorpromazine above the recommended intake limit
Advertisement
Was this product in your home? Find safe, vetted alternatives. We may earn a commission on qualifying purchases.
Browse Safer Alternatives
Recall Number D-0012-2026
Classification Class II
Status Ongoing
Category drug
Initiated 2025-09-12
Reported 2025-10-15
Distribution Nationwide
Code Info Lots N01920, Exp. Date, 12/31/2025, N02023, Exp. Date, 02/28/2026 & N02202, Exp. Date, 06/30/2026 Source: openFDA enforcement report. WhichRecall is not affiliated with the FDA. See our disclaimer .